Anti-CD20 to Control Antibody Formation Against FVIII In Gene and Protein Replacement Therapy

被引：0
|
作者：
Sack, Brandon [1 ]
Moghimi, Babak [1 ]
Byrne, Barry [1 ]
Herzog, Roland W. [1 ]
机构：
[1] Univ Florida, Pediat CMT, Gainesville, FL USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：313 / 314
页数：2
相关论文
共 50 条
  • [1] Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice
    Zhang, Ai-Hong
    Skupsky, Jonathan
    Scott, David W.
    [J]. BLOOD, 2011, 117 (07) : 2223 - 2226
  • [2] What signals are generated by anti-CD20 antibody therapy?
    Bonavida B.
    [J]. Current Hematologic Malignancy Reports, 2006, 1 (4) : 205 - 213
  • [3] Anti-CD20 monoclonal antibody therapy in multiple myeloma
    Kapoor, Prashant
    Greipp, Patricia T.
    Morice, William G.
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    Greipp, Philip R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 135 - 148
  • [4] Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia
    Elsegeiny, Waleed
    Eddens, Taylor
    Chen, Kong
    Kolls, Jay K.
    [J]. INFECTION AND IMMUNITY, 2015, 83 (05) : 2043 - 2052
  • [5] Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
    Tallantyre, E. C.
    Whittam, D. H.
    Jolles, S.
    Paling, D.
    Constantinesecu, C.
    Robertson, N. P.
    Jacob, A.
    [J]. JOURNAL OF NEUROLOGY, 2018, 265 (05) : 1115 - 1122
  • [6] Combination therapy with the type II anti-CD20 antibody obinutuzumab
    Klein, Christian
    Bacac, Marina
    Umana, Pablo
    Fingerle-Rowson, Gunter
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (10) : 1145 - 1162
  • [7] Efficacy of Accelerated Vaccination against Hbv to Achieve Antibody formation in Multiple Sclerosis Patients Receiving Anti-Cd20 Therapy
    Koc, Emine Rabia
    Turan, Omer Faruk
    Saridas, Furkan
    Menguc, Bedirhan
    Minaz, Sema Nur
    Ozkaya, Guven
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2023, 26 (05) : 697 - 701
  • [8] Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
    E. C. Tallantyre
    D. H. Whittam
    S. Jolles
    D. Paling
    C. Constantinesecu
    N. P. Robertson
    A. Jacob
    [J]. Journal of Neurology, 2018, 265 : 1115 - 1122
  • [9] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    Zent, Clive S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 876 - 877
  • [10] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
12345